|
(1) - Chemical agents for scientific and medical research use, namely, macromolecules for the purpose of supporting the viability and function of therapeutic transplants including medical device and cell therapy transplants, for use in the research, discovery and development of implantable medical devices and cell therapies; chemical agents for coating of implantable medical devices and for encapsulating pharmaceutical agents and cells for the purpose of supporting the viability and function of therapeutic transplants including medical device and cell therapy transplants.
(2) - Hormone replacement therapy preparations; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for use in immunomodulation therapies; surgical implants comprised of living tissues; surgical implants grown from stem cells
(3) - Pharmaceutical preparations for the treatment of endocrine diseases and oncological diseases; stem cells for medical purposes; stem cells and progenitor cells for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system; stem cells and progenitor cells for use in the production of biologic substances, namely, growth factors and proteins for medical purposes
(4) - Implants including artificial materials for medical use and diagnostic use; coatings sold as an integral component of implantable medical devices, namely, polymers and chemical compounds
(5) - Research and development of immune system treatments; Medical and scientific research in the field of stem cell therapy and cell transplantation therapies; Medical research; biopharmaceutical development, research and evaluation of stem cell-based therapeutics for the treatment of diseases and disorders; production of therapeutical cellular products, active ingredients production for cell based therapies; medical treatment using cultured cells; stem cell therapy services
|